Page last updated: 2024-08-17

mannitol and picibanil

mannitol has been researched along with picibanil in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Doki, Y; Hoffman, EW; Isobe, M; Iwatsuki, K; Kakimi, K; Kiura, K; Nakajima, J; Nakayama, E; Naomoto, Y; Oka, M; Old, LJ; Pan, L; Sato, E; Seto, Y; Shiraishi, K; Takigawa, N; Tsuji, K; Uenaka, A; Wada, H; Yamatsuji, T	1

Trials

1 trial(s) available for mannitol and picibanil

Article	Year
A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen. International journal of cancer, 2011, Dec-15, Volume: 129, Issue:12 Topics: Adult; Aged; Antigens; Antigens, Neoplasm; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Humans; Immunity, Humoral; Male; Mannitol; Membrane Proteins; Middle Aged; Neoplasms; Oleic Acids; Peptide Fragments; Picibanil; Treatment Outcome; Vaccines, Subunit	2011

Article

Year

A phase I study of vaccination with NY-ESO-1f peptide mixed with Picibanil OK-432 and Montanide ISA-51 in patients with cancers expressing the NY-ESO-1 antigen.

International journal of cancer, 2011, Dec-15, Volume: 129, Issue:12

Topics: Adult; Aged; Antigens; Antigens, Neoplasm; Cancer Vaccines; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Female; Humans; Immunity, Humoral; Male; Mannitol; Membrane Proteins; Middle Aged; Neoplasms; Oleic Acids; Peptide Fragments; Picibanil; Treatment Outcome; Vaccines, Subunit

2011